USD 2.11
(-8.26%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 10.91 Million CAD | -34.21% |
2022 | 16.58 Million CAD | -46.63% |
2021 | 31.07 Million USD | 267.87% |
2020 | 8.44 Million CAD | 54.33% |
2019 | 5.47 Million CAD | -0.04% |
2018 | 5.47 Million CAD | 278.7% |
2017 | 1.44 Million CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | -100.0% |
2006 | 3597.00 CAD | 8.31% |
2005 | 3321.00 CAD | 552.46% |
2004 | 509.00 CAD | -83.5% |
2003 | 3084.00 CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 6.5 Million CAD | -34.12% |
2024 Q1 | 8.68 Million CAD | -20.45% |
2023 Q1 | 16.15 Million USD | -2.59% |
2023 Q2 | 14.48 Million CAD | -10.35% |
2023 Q4 | 10.91 Million CAD | -1.08% |
2023 FY | 10.91 Million CAD | -34.21% |
2023 Q3 | 11.03 Million CAD | -23.84% |
2022 Q2 | 28.13 Million CAD | -13.38% |
2022 Q3 | 16.63 Million CAD | -40.88% |
2022 Q1 | 32.48 Million CAD | 4.53% |
2022 Q4 | 16.58 Million CAD | -0.29% |
2022 FY | 16.58 Million CAD | -46.63% |
2021 Q2 | 17.69 Million CAD | 19.27% |
2021 Q1 | 14.84 Million CAD | 75.66% |
2021 Q3 | 26.63 Million CAD | 50.47% |
2021 Q4 | 31.07 Million USD | 16.69% |
2021 FY | 31.07 Million USD | 267.87% |
2020 Q2 | 11.19 Million CAD | 8.36% |
2020 Q4 | 8.44 Million CAD | -24.69% |
2020 Q3 | 11.21 Million CAD | 0.22% |
2020 Q1 | 10.32 Million CAD | 29.32% |
2020 FY | 8.44 Million CAD | 54.33% |
2019 Q1 | 4.26 Million CAD | -22.21% |
2019 FY | 5.47 Million CAD | -0.04% |
2019 Q2 | 7.14 Million CAD | 67.79% |
2019 Q3 | 5.72 Million CAD | -19.98% |
2019 Q4 | 7.98 Million CAD | 39.63% |
2018 Q1 | - CAD | 0.0% |
2018 FY | 5.47 Million CAD | 278.7% |
2018 Q4 | 5.47 Million CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 FY | 1.44 Million CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2007 Q1 | 3597.00 CAD | -64.99% |
2007 Q3 | 2838.00 CAD | 16.74% |
2007 Q2 | 2431.00 CAD | -32.42% |
2007 FY | - CAD | -100.0% |
2007 Q4 | - CAD | -100.0% |
2006 Q4 | 10.27 Thousand CAD | 61.15% |
2006 FY | 3597.00 CAD | 8.31% |
2006 Q2 | 2951.00 CAD | -11.14% |
2006 Q1 | 3321.00 CAD | -10.19% |
2006 Q3 | 6375.00 CAD | 116.03% |
2005 Q4 | 3698.00 CAD | 162.08% |
2005 FY | 3321.00 CAD | 552.46% |
2005 Q1 | 509.00 CAD | -87.63% |
2005 Q3 | 1411.00 CAD | -94.27% |
2005 Q2 | 24.61 Thousand CAD | 4736.54% |
2004 Q3 | 168.85 Thousand CAD | 10065.62% |
2004 Q4 | 4115.00 CAD | -97.56% |
2004 Q1 | 3084.00 CAD | -11.63% |
2004 FY | 509.00 CAD | -83.5% |
2004 Q2 | 1661.00 CAD | -46.14% |
2003 Q3 | 1055.00 CAD | 0.0% |
2003 Q2 | - CAD | 0.0% |
2003 FY | 3084.00 CAD | 0.0% |
2003 Q4 | 3490.00 CAD | 230.81% |
Name | Inventory | Inventory Difference |
---|---|---|
Theratechnologies Inc. | 6.06 Million USD | -79.888% |
Harrow Health, Inc. | 10.86 Million USD | -0.414% |
Dynavax Technologies Corporation | 53.29 Million USD | 79.523% |
Biofrontera Inc. | 10.9 Million USD | -0.037% |
Cronos Group Inc. | 30.33 Million USD | 64.033% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -301.324% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1091199900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -91.471% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -136.736% |
Radius Health, Inc. | 278.64 Million USD | 96.084% |
Universe Pharmaceuticals INC | 3.34 Million USD | -226.387% |
DURECT Corporation | 2.21 Million USD | -391.753% |
ProPhase Labs, Inc. | 3.84 Million USD | -184.093% |
Safety Shot Inc | 1.86 Million USD | -483.64% |
Phibro Animal Health Corporation | 265.91 Million USD | 95.896% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1247.565% |
Alvotech | 74.43 Million USD | 85.34% |
Assertio Holdings, Inc. | 37.68 Million USD | 71.045% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 85.903% |
Rockwell Medical, Inc. | 5.87 Million USD | -85.863% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -90.278% |
Procaps Group S.A. | 96.83 Million USD | 88.731% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 6.311% |
SCYNEXIS, Inc. | - USD | -Infinity% |
Aytu BioPharma, Inc. | 12.63 Million USD | 13.623% |
Viatris Inc. | 3.46 Billion USD | 99.686% |
OptiNose, Inc. | 8.05 Million USD | -35.519% |
SIGA Technologies, Inc. | 64.21 Million USD | 83.008% |
Tilray Brands, Inc. | 252.08 Million USD | 95.671% |
PetIQ, Inc. | 159.3 Million USD | 93.15% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -90.278% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 71.509% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -307.603% |
Alimera Sciences, Inc. | 1.87 Million USD | -480.734% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 66.25% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Organogenesis Holdings Inc. | 28.25 Million USD | 61.378% |
Journey Medical Corporation | 10.2 Million USD | -6.917% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -577.599% |
Alpha Teknova, Inc. | 11.59 Million USD | 5.882% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -143.408% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 72.706% |
PainReform Ltd. | - USD | -Infinity% |
Cosmos Health Inc. | 4.78 Million USD | -127.853% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -5.125% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 92.826% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 7242.39% |
Talphera, Inc. | - USD | -Infinity% |
Pacira BioSciences, Inc. | 104.35 Million USD | 89.543% |
Incannex Healthcare Limited | -10.01 Million USD | 208.957% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4190.118% |
Shineco, Inc. | 1.58 Million USD | -586.927% |
Procaps Group, S.A. | 96.83 Million USD | 88.731% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 90.187% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -61.205% |
Lantheus Holdings, Inc. | 64.02 Million USD | 82.958% |
Alvotech | 74.43 Million USD | 85.34% |
Hempacco Co., Inc. | 2.54 Million USD | -329.162% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 77.169% |
Bright Green Corporation | - USD | -Infinity% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 83.372% |
Kamada Ltd. | 87.74 Million USD | 87.564% |
Indivior PLC | 141.79 Million USD | 92.305% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -2164.652% |
Flora Growth Corp. | 8.5 Million USD | -28.256% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4190.118% |
Evolus, Inc. | 10.99 Million USD | 0.782% |
HUTCHMED (China) Limited | 50.25 Million USD | 78.288% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 89.689% |
Akanda Corp. | 1.28 Million USD | -747.933% |